In a recent study published in the journal Nature, researchers from the United States of America developed the synthetic intramembrane proteolysis receptor (SNIPR) architecture to activate engineered ...
As a synthetic decapeptide structurally derived from gonadotropin-releasing hormone (GnRH), Triptorelin has long attracted research interest due to its unusually paradoxical signalling profile.
A growing body of preclinical research points to the TIE2 receptor and its angiopoietin ligands as a promising drug target ...
Preliminary safety, antitumor activity, and pharmacodynamics of intratumoral ABO2011 (IL-12 mRNA) in patients with advanced solid tumors. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...